|Day Low/High||0.37 / 0.46|
|52 Wk Low/High||0.44 / 2.75|
TherapeuticsMD and Spark Networks are beaten-down names with recent buying interest from insiders in common.
Dynavax Technologies, Kala Pharmaceuticals and TherapeuticsMD are three names this biotech investor plans to add exposure to via covered calls.
TherapeuticsMD and Thor Industries are in wholly unrelated sectors, but both stocks look undervalued over the long term.
BioDelivery Sciences International, Chiasma Inc. and TherapeticsMD all feature promising treatments.
In the daily bar chart of TherapeuticsMD we can see that prices are in a downtrend from June.
This week we'll get regional economic and housing data, a GDP report plus fourth-quarter earnings.
We used this week's declines to add to our positions in Teligent, Builders FirstSource and Sonus Networks.
The portfolio has outperformed the Russell 2000 index by more than 400 basis points, year to date.
Biotechs are leading, which tells me there's enough speculative interest.
We're looking to add to our positions in companies we believe can outperform in coming quarters
Market struggles to hold support and not fall into a deeper downtrend.